✦ LIBER ✦

The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease

✍ Scribed by David J. Gill; Arielle Freshman; Jennifer A. Blender; Bernard Ravina

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 75 KB
Volume: 23
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.22017

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysfunction in PD. The test–retest intraclass correlation coefficient was 0.79 and the interrater intraclass correlation coefficient was 0.81. The correlation coefficient between the MoCA and a neuropsychologic battery was 0.72. The MoCA is reliable and valid in the PD population and warrants further study as a screening tool for cognitive dysfunction. © 2008 Movement Disorder Society

📜 SIMILAR VOLUMES

The Montreal Cognitive Assessment: A scr

The Montreal Cognitive Assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder

✍ Jean-François Gagnon; Ronald B. Postuma; Steve Joncas; Catherine Desjardins; Vér 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

A correct balance between endocannabinoid and dopamine-dependent systems is believed to underlie physiological motor control. We measured the levels of the endocannabinoid anandamide in the cerebrospinal fluid of Parkinson's disease (PD) patients. Subjects were divided into three groups: newly diagn

Cognitive impairment in Parkinson's dise

Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment

✍ Jaime Kulisevsky; Javier Pagonabarraga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Cognitive impairment (CI) and dementia are frequent and debilitating features associated with Parkinson's disease (PD). Formal neuropsychological examination is required to ascertain the degree and pattern of CI over the course of the disease. The use of different tools may explain hete

Characteristics of the GPCOG, a screenin

Characteristics of the GPCOG, a screening tool for cognitive impairment

✍ Henry Brodaty; Nicola M. Kemp; Lee-Fay Low 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract ## Background Early dementia diagnosis is aided by the use of brief screening tests; scores can be biased by patient and informant characteristics such as age, gender and education. ## Objective To assess whether the General Practitioner's Assessment of Cognition (GPCOG), a brief scr

A comparison of the mini mental state ex

A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease

✍ Cindy Zadikoff; Susan H. Fox; David F. Tang-Wai; Teri Thomsen; Rob M.A. de Bie; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract Dementia is an important and increasingly recognized problem in Parkinson's disease (PD). The mini‐mental state examination (MMSE) often fails to detect early cognitive decline. The Montreal cognitive assessment (MoCA) is a brief tool developed to detect mild cognitive impairment that a

PDD-Short Screen: A brief cognitive test

PDD-Short Screen: A brief cognitive test for screening dementia in Parkinson's disease

✍ Javier Pagonabarraga; Jaime Kulisevsky; Gisela Llebaria; Carmen García-Sánchez; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract The diagnosis of Parkinson's disease with dementia (PDD) is currently based on clinical criteria (DSM‐IV, MDS–Task Force). In daily practice and research studies, these criteria still depend on the subjective impression of the examiner. Brief screening tests (BST) are helpful in identif

A recommended scale for cognitive screen

✍ Kelvin L. Chou; Melissa M. Amick; Jason Brandt; Richard Camicioli; Karen Frei; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract Cognitive impairment is common in Parkinson's disease (PD). There is a critical need for a brief, standard cognitive screening measure for use in PD trials whose primary focus is not on cognition. The Parkinson Study Group (PSG) Cognitive/Psychiatric Working Group formed a Task Force to